Characterization of isoleucyl-tRNA synthetase from Staphylococcus aureus. II. Mechanism of inhibition by reaction intermediate and pseudomonic acid analogues studied using transient and steady-state kinetics

J Biol Chem. 1998 Nov 27;273(48):31691-701. doi: 10.1074/jbc.273.48.31691.

Abstract

The interactions of isoleucyl-tRNA synthetase (IleRS, E) from Staphylococcus aureus with both intermediate analogues and pseudomonic acid (PS-A) have been investigated using transient and steady-state techniques. Non-hydrolyzable analogues of isoleucyl-AMP (I) were simple competitive inhibitors (Ile-ol-AMP, Ki = 50 nM and Ile-NHSO2-AMP, Ki = 1 nM;). PS-A (J) inhibits IleRS via a slow-tight binding competitive mechanism where E.J (Kj = approximately 2 nM), undergoes an isomerization to form a stabilized E*.J complex (K*j = 50 pM). To overcome tight-binding artifacts when K*j << [E], K*j values were estimated from PPi/ATP exchange where [S] >> Km, thus raising K*j,app well above [E]. Using [3H]PS-A, it was confirmed that binding occurs with 1:1 stoichiometry and is reversible. Formation of inhibitor complexes was monitored directly through changes in enzyme tryptophan fluorescence. For Ile-ol-AMP and Ile-NHSO2-AMP, the fluorescence intensity of E.I was identical to that when E.Ile-AMP forms catalytically. Binding of PS-A induced only a small change in IleRS fluorescence that was characterized using transient kinetic competition. SB-205952, a PS-A analogue, produced a 37% quenching of IleRS fluorescence upon binding as a result of radiationless energy transfer. Inhibitor reversal rates were obtained by measuring relaxation between spectroscopically different complexes. Together, these data represent a comprehensive solution to the kinetics of inhibition by these compounds.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Isoleucine / metabolism
  • Isoleucine-tRNA Ligase / antagonists & inhibitors
  • Isoleucine-tRNA Ligase / metabolism*
  • Kinetics
  • Models, Chemical
  • Molecular Structure
  • Mupirocin / analogs & derivatives*
  • Mupirocin / pharmacology*
  • Staphylococcus aureus / enzymology*
  • Structure-Activity Relationship

Substances

  • Anti-Bacterial Agents
  • Isoleucine
  • Mupirocin
  • Isoleucine-tRNA Ligase